Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Oggianu
Institution:
Angelini Pharma (Italy)
Observed institution:
Angelini Pharma (Italy)
ORCID:
0000-0002-2474-2872
Observed ORCID:
0000-0002-2474-2872
OpenAlex ID:
A5000150395
Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model
2020
·
Federica Prati
, Rosa Buonfiglio
, et al.
·
ACS Medicinal Chemistry Letters
·
26
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
2022
·
Laura Oggianu
, Giorgio Di Dato
, et al.
·
Clinical and Translational Science
·
18
PDF
Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone–Atomoxetine Interaction
2019
·
Laura Oggianu
, Alice B. Ke
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
12
PDF
PK / PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development
2023
·
Laura Oggianu
, Beatrice Garrone
, et al.
·
Clinical and Translational Science
·
8
PDF
Juvenile Rat and Pediatric Trazodone Studies: How to Gain Extra Sensitivity to Overcome Bioanalytical Challenges
2018
·
Silvana Olivieri
, Graziella Bovi
, et al.
·
Bioanalysis
·
4
Characterization of trazodone metabolic pathways and species-specific profiles
2025
·
Vanessa Petrucci
, Patrizia Dragone
, et al.
·
Frontiers in Pharmacology
·
3
PDF
Show more works
View as search
Works count:
6
Citation count:
71
H-index:
4
I10-index:
3
Year
Topic
Type
